Logo-ajpr
Submitted: 29 May 2022
Revision: 08 Jun 2022
Accepted: 10 Jun 2022
ePublished: 30 Jun 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Avicenna J Pharm Res. 2022;3(1): 1-7.
doi: 10.34172/ajpr.2022.1066
  Abstract View: 218
  PDF Download: 182

Original Article

Patterns of Intravenous Human Immunoglobulin Administration in a Middle Eastern Teaching Hospital

Yasmin Zabihi 1 ORCID logo, Maryam Etminaniesfahani 2, Maryam Rangchian 2* ORCID logo

1 Pharmacy School, Hamadan University of Medical Sciences, Hamadan, Iran
2 Department of Clinical Pharmacy, Pharmacy School, Hamadan University of Medical Sciences, Hamadan, Iran
*Corresponding Author: Maryam Rangchian, Emails: m.rangchian@umsha. ac.ir, , Email: m.rangchian89@gmail.com

Abstract

Background: Drug use evaluation (DUE) helps to investigate and modify the pattern of drug administration with the aim of improving patient care and cost saving. Considering the important indications for intravenous immunoglobulin (IVIG) and its high cost, assessment of its prescription pattern could be helpful in increasing the efficiency of the health system.This study aimed to investigate the pattern of IVIG use in a tertiary teaching hospital.

Methods: This retrospective study included all inpatients who received IVIG in spring and summer 2020. The needed information was extracted from patients’ files. Data were analyzed using SPSS and compared with the standard guidelines.

Results: A total of 72 patients received IVIG. The indications were “FDA-approved” and “CEDITacknowledged” in 33.3% and 61.1% of the cases, respectively, and 45.8% adhered to the “red” indications of the UK protocol. Moreover, all prescriptions were in accordance with the approved indications of the FDO (Iranian Food and Drug Organization) guideline. Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy, and COVID-19 were the three most common causes of IVIG administration. Additionally, 66.7% had received the recommended dose regimen and 51.3% experienced drug side effects requiring some measures.

Conclusion: The occurrence of adverse drug reactions in more than half of the studied patients and related costs substantiate the need for enhancing physicians’ refrain from the unnecessary prescription of the IVIG, nursing staff’s knowledge, and the inclusion of a clinical pharmacist in the healthcare team.


Please cite this article as follows: Zabihi Y, Etminaniesfahani M, Rangchian M. Patterns of intravenous human immunoglobulin administration in a Middle Eastern teaching hospital. Avicenna J Pharm Res. 2022; 3(1):1-7. doi:10.34172/ajpr.2022.1066
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 219

Your browser does not support the canvas element.


PDF Download: 182

Your browser does not support the canvas element.